28Jun/13

GlobalData: Upcoming Novartis chronic heart failure drug expected to dominate … – PharmaLive (press release) (subscription)

GlobalData: Upcoming Novartis chronic heart failure drug expected to dominate
PharmaLive (press release) (subscription)
Research and consulting firm GlobalData has released a new report, PharmaPoint: Chronic Heart Failure – Global Drug Forecast and Market Analysis to 2022 and forecasts global sales of Novartis’ combination drug LCZ-696 to reach a massive $1.86 billion 

and more »

28Jun/13

GlobalData Expects New Novartis Heart Failure Drug to Reach $1.9 Billion … – PharmaLive (press release) (subscription)

GlobalData Expects New Novartis Heart Failure Drug to Reach $1.9 Billion
PharmaLive (press release) (subscription)
LONDON, UK (GlobalData), 20 June 2013 – Following a launch scheduled for 2015 for the treatment of Chronic Heart Failure (CHF), Novartis’ novel combination drug LCZ-696 will rapidly dominate the global CHF therapeutics sector and mark a drug 

28Jun/13

Critics Are Tearing Channing Tatum's New 'White House' Movie Down – Business Insider


Business Insider

Critics Are Tearing Channing Tatum’s New ‘White House’ Movie Down
Business Insider
White House Down, rated PG-13 but as crass and cynical as a Michael Bay movie, is a depressing experience.” WSJ: “‘White House Down’ is solidly within its genre. In a deeper sense, though, it bespeaks a fatigue that’s hard to distinguish from brain
‘House’ Is a Home for Tired Action TropesWall Street Journal- India
‘White House Down’ Gets Mediocre ReviewsUinterview.com
White House Down Gets Thumbs Down From Critics: ReviewTheImproper.com

all 746 news articles »